1035485-64-3

Upstream product

• 1198320-08-9 (S)-N₁-(4-(4-chlorophenoxy)phenyl)-N₂-(2-(methanesulfonyl)ethyl)-1-(3-(trifluoromethyl) phenyl)ethane-1,2-diamine 
• 530-62-1 1,1'-carbonyldiimidazole 
• 1035485-61-0 (S)-1-[4-(4-chloro-phenoxy)-phenyl]-5-(3-trifluoromethyl-phenyl)-imidazolidin-2-one 
• 3680-02-2 methyl ethenyl sulphone 

Relevant academic research and scientific papers

Facile and practical synthesis of a cannabinoid-1 antagonist via regio- and stereoselective ring-opening of an aziridinium ion

A scalable synthetic strategy of a chiral, trisubstituted imidazolidinone (1), a novel cannabinoid-1 antagonist, starting from a commercially available mandelic acid (5) is described. The key step involves a regio- and stereoselective ring-opening of an a

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).